CLASSIFIED GP (08232) announced that effective September 30, 2025, the company has undergone significant board restructuring.

The following resignations took effect on September 30, 2025: - Mr. Wong Tsz Chiu resigned as Executive Director and Chairman of the Board - Mr. Pong Kin Yi resigned as Executive Director - Mr. Lee Kai Leung resigned as Executive Director - Mr. Chan Kin Keung resigned as Independent Non-executive Director, member of the Board Audit Committee, member of the Board Nomination Committee, and Chairman of the Board Remuneration Committee - Mr. Ng Chun Fai resigned as Independent Non-executive Director, member of the Audit Committee, member of the Remuneration Committee, and Chairman of the Nomination Committee - Mr. Yu Man Yiu resigned as Independent Non-executive Director, Chairman of the Audit Committee, member of the Nomination Committee, and member of the Remuneration Committee - Ms. Wong Chui Yu resigned as Independent Non-executive Director, member of the Audit Committee, member of the Nomination Committee, and member of the Remuneration Committee

Concurrently, the following appointments were made effective September 30, 2025: - Mr. Kwok Chun Kwan was appointed as Chairman, Executive Director, member of the Nomination Committee, and member of the Remuneration Committee - Mr. Chan Cheuk Hei was appointed as Executive Director - Ms. Ho Ka Yi was appointed as Executive Director - Mr. Wong Ho Shing was appointed as Independent Non-executive Director, Chairman of the Audit Committee, member of the Nomination Committee, and Chairman of the Remuneration Committee - Ms. Chan Sheung Yu was appointed as Independent Non-executive Director, member of the Audit Committee, Chairman of the Nomination Committee, and member of the Remuneration Committee - Mr. Lau Kei Lik was appointed as Independent Non-executive Director, member of the Audit Committee, member of the Nomination Committee, and member of the Remuneration Committee

Additionally, Mr. Wong Tsz Chiu resigned as the company's authorized representative, effective September 30, 2025. Mr. Kwok has been appointed as the company's authorized representative, also effective September 30, 2025.